Authors: BATTIE MM WEINRYB I NEEFE DL KLAMERUS KJ BURGHART PH MAYER PR

Citation: Mm. Battie et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TASOSARTAN AND ENALAPRIL IN HYPERTENSIVES, Journal of hypertension, 16, 1998, pp. 1547-1547

Authors: BATTLE MM KLAMERUS KJ NEEFE DL GEORGIEFF IS MAYER PR

Citation: Mm. Battle et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF THE POTENTIAL-DRUG INTERACTION BETWEEN TASOSARTAN AND WARFARIN IN HEALTHY-SUBJECTS, Journal of hypertension, 16, 1998, pp. 1567-1567

Authors: BATTLE MM ABOUGHARBI N KLAMERUS KJ NEEFE DL WEINRYB I BURGHART PH MAYER PR

Citation: Mm. Battle et al., INFLUENCE OF A HIGH-FAT MEAL ON THE BIOAVAILABILITY OF TASOSARTAN, Journal of hypertension, 16, 1998, pp. 31007-31007

Authors: FERRON GM PAUL J FRUNCILLO RJ MARTIN PT YACOUB L MAYER PR

Citation: Gm. Ferron et al., A PHARMACOKINETIC STUDY OF THE POTENTIAL-DRUG INTERACTION BETWEEN ORAL PANTOPRAZOLE AND CISAPRIDE IN HEALTHY-ADULTS, Gastroenterology, 114(4), 1998, pp. 48-48

Authors: MAYER PR

Citation: Pr. Mayer, ABSORPTION, METABOLISM, AND OTHER FACTORS THAT INFLUENCE DRUG EXPOSURE IN TOXICOLOGY STUDIES, Toxicologic pathology, 23(2), 1995, pp. 165-169